e-Article
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial
Document Type
Article
Author
Kindler, Hedy L ; Novello, Silvia; Bearz, Alessandra; Ceresoli, Giovanni L; Aerts, Joachim G J V; Spicer, James; Taylor, Paul; Nackaerts, Kristiaan; Greystoke, Alastair; Jennens, Ross; Calabrò, Luana; Burgers, Jacobus A; Santoro, Armando; Cedrés, Susana; Serwatowski, Piotr; Ponce, Santiago; Van Meerbeeck, Jan P; Nowak, Anna K; Blumenschein, George, Jr; Siegel, Jonathan M; Kasten, Linda; Köchert, Karl; Walter, Annette O; Childs, Barrett H; Elbi, Cem; Hassan, Raffit; Fennell, Dean A
Source
In The Lancet Oncology April 2022 23(4):540-552
Subject
Language
ISSN
1470-2045